Clinical Trials
68 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Kalbe International Pte. Ltd
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
The Suitability of Sniff Dog as a Tool in Screening Tumors
Central South University
TUM-DC
University of Milano Bicocca
ILST
The University of Queensland
SOLUCOM
Vestre Viken Hospital Trust
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
IMMUNOs-SBRT
Centre Georges Francois Leclerc
Patient-Derived Xenografts to Reduce Cancer Health Disparities
University of California, Davis
CAT_PB
Lebanese University
LUCACRIMUNO
Lithuanian University of Health Sciences
Increasing Physical Activity Through Personalised Motivational Messaging to Improve Cognitive Function in Lung Cancer Survivors
The University of Hong Kong
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Shanghai EpimAb Biotherapeutics Co., Ltd.
ELISA
Assistance Publique - Hôpitaux de Paris
Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer
PlusVitech S.L.
PRECISION
LMU Klinikum
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
RESTORE
Blue Note Therapeutics
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
MICROBIOME
Imperial College London
'Lung Health Check' Biomarker Study
Royal Marsden NHS Foundation Trust
PASSION
Assistance Publique - Hôpitaux de Paris
SALMON
OncoRadiomics
PEN-866 in Patients With Advanced Solid Malignancies
Tarveda Therapeutics
GOLF
Royal Marsden NHS Foundation Trust
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
PREVALUNG
Centre Chirurgical Marie Lannelongue
Idylla EGFR Lung Trial
Protean BioDiagnostics
MIRACLE
Kyunghee University Medical Center
Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients
Universidade Nova de Lisboa
Routine Electronic Monitoring Of Quality Of Life -Poumon (REMOQOL-Poumon)
Centre Hospitalier Universitaire de Besancon
IMPE-F
Northumbria Healthcare NHS Foundation Trust
MRI Lung
The Clatterbridge Cancer Centre NHS Foundation Trust
PIONEER
SpeciCare
EPIC
University of Turin, Italy
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Ardigen
AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.
Ardigen
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Oncogeriatric Intervention and Follow-up at Home
University of Aarhus
ICI-DISCOVER
Università Politecnica delle Marche
Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
The First Affiliated Hospital with Nanjing Medical University
The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients
The First Affiliated Hospital of Dalian Medical University
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano